Immunoprecise Antibodies Ltd expected to post a loss of 23 cents a share - Earnings Preview

Mindwalk Holdings

14/03/2023 14:11

* Immunoprecise Antibodies Ltd  IPA.OQ   IPA.O  is expected
to show a rise in quarterly revenue when it reports  results on
March 16. 
    * The Vancouver British Columbia-based  company is expected
to
report  a 12.8% increase in revenue to C$5.434 million from
C$4.82 million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Immunoprecise
Antibodies
Ltd is for a loss of 23 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
Immunoprecise
Antibodies Ltd is $10.5​, above​ its last closing price
of $3.82. ​​​

This summary was machine generated March 14 at 14:11 GMT.  All
figures in Canadian dollars  unless otherwise stated